The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 26,446,970 | 3,269,094 | SH | SOLE | 3,269,094 | 0 | 0 | ||
ADAPTIVE BIOTECHNOLOGIES COR | COM | 00650F109 | 5,725,822 | 648,451 | SH | SOLE | 648,451 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 19,847,090 | 3,206,315 | SH | SOLE | 3,206,315 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 69,210,418 | 207,130 | SH | SOLE | 207,130 | 0 | 0 | ||
ALPHATEC HLDGS INC | NOTE 0.750% 8/0 | 02081GAB8 | 108,210,938 | 101,250,000 | PRN | SOLE | 101,250,000 | 0 | 0 | ||
ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 5,649,548 | 1,249,900 | SH | SOLE | 1,249,900 | 0 | 0 | ||
AMGEN INC | COM | 031162100 | 39,042,625 | 161,500 | SH | SOLE | 161,500 | 0 | 0 | ||
AMYRIS INC | NOTE 1.500%11/1 | 03236MAJ0 | 39,080,475 | 137,850,000 | PRN | SOLE | 137,850,000 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 21,174,068 | 973,073 | SH | SOLE | 973,073 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 10,284,378 | 333,800 | SH | SOLE | 333,800 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | 9,165,468 | 24,600 | SH | SOLE | 24,600 | 0 | 0 | ||
AVALO THERAPEUTICS INC | COM NEW | 05338F207 | 432,695 | 247,254 | SH | SOLE | 247,254 | 0 | 0 | ||
AXONICS INC | COM | 05465P101 | 9,095,370 | 166,704 | SH | SOLE | 166,704 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 29,708,597 | 4,126,194 | SH | SOLE | 4,126,194 | 0 | 0 | ||
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | 16,222,418 | 1,945,134 | SH | SOLE | 1,945,134 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 61,372,898 | 220,742 | SH | SOLE | 220,742 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.250% 2/0 | 10806XAD4 | 27,379,090 | 42,294,000 | PRN | SOLE | 42,294,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 106,213,458 | 143,338,000 | PRN | SOLE | 143,338,000 | 0 | 0 | ||
COMPASS THERAPEUTICS INC | COM | 20454B104 | 10,620,460 | 3,247,847 | SH | SOLE | 3,247,847 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 32,436,607 | 2,019,714 | SH | SOLE | 2,019,714 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 42,247,796 | 3,159,895 | SH | SOLE | 3,159,895 | 0 | 0 | ||
DBV TECHNOLOGIES S A | SPONSORED ADR | 23306J101 | 20,462,157 | 12,107,785 | SH | SOLE | 12,107,785 | 0 | 0 | ||
DECIPHERA PHARMACEUTICALS IN | COM | 24344T101 | 50,078,873 | 3,241,351 | SH | SOLE | 3,241,351 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 28,214,520 | 984,800 | SH | SOLE | 984,800 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 15,873,085 | 1,377,872 | SH | SOLE | 1,377,872 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 41,989,256 | 1,038,310 | SH | SOLE | 1,038,310 | 0 | 0 | ||
ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 1,926,315 | 1,211,519 | SH | SOLE | 1,211,519 | 0 | 0 | ||
EXACT SCIENCES CORP | NOTE 0.375% 3/0 | 30063PAC9 | 122,748,869 | 139,000,000 | PRN | SOLE | 139,000,000 | 0 | 0 | ||
EXACT SCIENCES CORP | NOTE 0.375% 3/1 | 30063PAB1 | 45,183,667 | 48,300,000 | PRN | SOLE | 48,300,000 | 0 | 0 | ||
GLAUKOS CORP | COM | 377322102 | 90,513,215 | 1,806,651 | SH | SOLE | 1,806,651 | 0 | 0 | ||
GLOBUS MED INC | CL A | 379577208 | 18,985,728 | 335,200 | SH | SOLE | 335,200 | 0 | 0 | ||
GUARDANT HEALTH INC | NOTE 11/1 | 40131MAB5 | 168,847,260 | 250,022,000 | PRN | SOLE | 250,022,000 | 0 | 0 | ||
HARROW HEALTH INC | COM | 415858109 | 30,735,704 | 1,452,538 | SH | SOLE | 1,452,538 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 26,782,170 | 1,620,216 | SH | SOLE | 1,620,216 | 0 | 0 | ||
ILLUMINA INC | NOTE 8/1 | 452327AK5 | 1,087,736 | 11,100,000 | PRN | SOLE | 11,100,000 | 0 | 0 | ||
IMMATICS N.V | SHS | N44445109 | 2,223,780 | 322,287 | SH | SOLE | 322,287 | 0 | 0 | ||
IMMUNOCORE HLDGS PLC | ADS | 45258D105 | 21,066,878 | 426,110 | SH | SOLE | 426,110 | 0 | 0 | ||
INSMED INC | NOTE 0.750% 6/0 | 457669AB5 | 2,721,080 | 3,500,000 | PRN | SOLE | 3,500,000 | 0 | 0 | ||
INSMED INC | NOTE 1.750% 1/1 | 457669AA7 | 36,486,219 | 39,963,000 | PRN | SOLE | 39,963,000 | 0 | 0 | ||
INTUITIVE SURGICAL INC | COM NEW | 46120E602 | 57,000,466 | 223,120 | SH | SOLE | 223,120 | 0 | 0 | ||
INVITAE CORP | NOTE 2.000% 9/0 | 46185LAB9 | 14,842,012 | 16,781,000 | PRN | SOLE | 16,781,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | NOTE 0.125%12/1 | 462222AB6 | 33,800,477 | 36,533,000 | PRN | SOLE | 36,533,000 | 0 | 0 | ||
IONIS PHARMACEUTICALS INC | NOTE 4/0 | 462222AD2 | 48,125,250 | 52,740,000 | PRN | SOLE | 52,740,000 | 0 | 0 | ||
IRHYTHM TECHNOLOGIES INC | COM | 450056106 | 56,330,581 | 454,169 | SH | SOLE | 454,169 | 0 | 0 | ||
IVERIC BIO INC | COM | 46583P102 | 90,377,970 | 3,714,672 | SH | SOLE | 3,714,672 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | NOTE 3.000%10/1 | 48576UAA4 | 51,148,346 | 65,976,000 | PRN | SOLE | 65,976,000 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 27,863,762 | 348,036 | SH | SOLE | 348,036 | 0 | 0 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | 29,018,844 | 601,801 | SH | SOLE | 601,801 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 13,792,359 | 3,355,805 | SH | SOLE | 3,355,805 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | 27,104,746 | 1,473,084 | SH | SOLE | 1,473,084 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 8,617,698 | 550,300 | SH | SOLE | 550,300 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 16,805,360 | 452,000 | SH | SOLE | 452,000 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES INC | NOTE 2.625% 3/0 | 63009RAD1 | 121,832,851 | 145,520,000 | PRN | SOLE | 145,520,000 | 0 | 0 | ||
NATERA INC | COM | 632307104 | 54,534,020 | 982,241 | SH | SOLE | 982,241 | 0 | 0 | ||
NEOGENOMICS INC | NOTE 0.250% 1/1 | 64049MAB6 | 36,021,720 | 48,678,000 | PRN | SOLE | 48,678,000 | 0 | 0 | ||
NEOGENOMICS INC | NOTE 1.250% 5/0 | 64049MAA8 | 30,958,125 | 33,000,000 | PRN | SOLE | 33,000,000 | 0 | 0 | ||
NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 77,615,496 | 766,800 | SH | SOLE | 766,800 | 0 | 0 | ||
NEVRO CORP | COM | 64157F103 | 59,029,877 | 1,632,915 | SH | SOLE | 1,632,915 | 0 | 0 | ||
NEVRO CORP | NOTE 2.750% 4/0 | 64157FAC7 | 102,695,940 | 109,251,000 | PRN | SOLE | 109,251,000 | 0 | 0 | ||
NOVOCURE LTD | NOTE 11/0 | 67011XAB9 | 116,802,148 | 134,334,000 | PRN | SOLE | 134,334,000 | 0 | 0 | ||
NUVASIVE INC | NOTE 0.375% 3/1 | 670704AJ4 | 32,466,858 | 36,665,000 | PRN | SOLE | 36,665,000 | 0 | 0 | ||
NUVASIVE INC | NOTE 1.000% 6/0 | 670704AL9 | 51,148,812 | 51,500,000 | PRN | SOLE | 51,500,000 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 6,844,014 | 4,122,900 | SH | SOLE | 4,122,900 | 0 | 0 | ||
ORTHOPEDIATRICS CORP | COM | 68752L100 | 44,239,997 | 998,871 | SH | SOLE | 998,871 | 0 | 0 | ||
OUTSET MED INC | COM | 690145107 | 32,280,040 | 1,754,350 | SH | SOLE | 1,754,350 | 0 | 0 | ||
PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 12,706,734 | 1,097,300 | SH | SOLE | 1,097,300 | 0 | 0 | ||
PARAGON 28 INC | COM | 69913P105 | 18,755,185 | 1,098,722 | SH | SOLE | 1,098,722 | 0 | 0 | ||
PENUMBRA INC | COM | 70975L107 | 29,832,092 | 107,044 | SH | SOLE | 107,044 | 0 | 0 | ||
PULMONX CORP | COM | 745848101 | 13,005,627 | 1,163,294 | SH | SOLE | 1,163,294 | 0 | 0 | ||
REPLIMUNE GROUP INC | COM | 76029N106 | 1,300,924 | 73,665 | SH | SOLE | 73,665 | 0 | 0 | ||
SILK RD MED INC | COM | 82710M100 | 2,478,142 | 63,331 | SH | SOLE | 63,331 | 0 | 0 | ||
STERIS PLC | SHS USD | G8473T100 | 18,304,348 | 95,694 | SH | SOLE | 95,694 | 0 | 0 | ||
SUPERNUS PHARMACEUTICALS | NOTE 0.625% 4/0 | 868459AD0 | 6,515,368 | 6,500,000 | PRN | SOLE | 6,500,000 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 19,431,435 | 920,049 | SH | SOLE | 920,049 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 23,645,131 | 1,997,055 | SH | SOLE | 1,997,055 | 0 | 0 | ||
TRANSMEDICS GROUP INC | COM | 89377M109 | 7,456,300 | 98,459 | SH | SOLE | 98,459 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.250% 3/0 | 89422GAA5 | 27,868,050 | 28,350,000 | PRN | SOLE | 28,350,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | NOTE 2.500% 9/1 | 761299AB2 | 53,901,491 | 56,031,000 | PRN | SOLE | 56,031,000 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 49,472,775 | 1,319,978 | SH | SOLE | 1,319,978 | 0 | 0 | ||
VIR BIOTECHNOLOGY INC | COM | 92764N102 | 14,055,918 | 604,036 | SH | SOLE | 604,036 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 76,487,167 | 2,137,110 | SH | SOLE | 2,137,110 | 0 | 0 |